Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ECOR - electroCore, Inc.

Previous close
16.4
0.375   2.287%

Share volume: 557
Last Updated: Thu 26 Dec 2024 08:28:02 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%
$16.02
0.38
2.34%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
19%
Profitability 18%
Dept financing 22%
Liquidity 36%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.19%
1 Month
41.88%
3 Months
143.96%
6 Months
157.28%
1 Year
191.92%
2 Year
5,196.42%
Key data
Stock price
$16.40
P/E Ratio 
-2.74
DAY RANGE
$15.50 - $16.24
EPS 
-$2.17
52 WEEK RANGE
$5.74 - $17.89
52 WEEK CHANGE
$187.79
MARKET CAP 
39.004 M
YIELD 
N/A
SHARES OUTSTANDING 
6.447 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
-0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$210,265
AVERAGE 30 VOLUME 
$143,855
Company detail
CEO: Daniel S. Goldberger
Region: US
Website: electrocore.com
Employees: 50
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

electroCore is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Recent news